These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 8088602

  • 1. Uterine papillary serous carcinoma: patterns of metastatic spread.
    Goff BA, Kato D, Schmidt RA, Ek M, Ferry JA, Muntz HG, Cain JM, Tamimi HK, Figge DC, Greer BE.
    Gynecol Oncol; 1994 Sep; 54(3):264-8. PubMed ID: 8088602
    [Abstract] [Full Text] [Related]

  • 2. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
    Wu M, Lang J, Guo L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
    [Abstract] [Full Text] [Related]

  • 5. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE, Asrari F, Trimble EL, Montz FJ.
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE.
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histologic characterization of uterine papillary serous adenocarcinoma.
    Miller B, Umpierre S, Tornos C, Burke T.
    Gynecol Oncol; 1995 Mar; 56(3):425-9. PubMed ID: 7705679
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N, Hareyama H, Todo Y, Yamada H, Yamamoto R, Fujino T, Sagawa T, Fujimoto S.
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [Abstract] [Full Text] [Related]

  • 16. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villà S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A, Rare Cancer Network.
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.
    Greggi S, Mangili G, Scaffa C, Scala F, Losito S, Iodice F, Pisano C, Montoli S, Viganò R, Pirozzi G, Giannarelli D.
    Int J Gynecol Cancer; 2011 May; 21(4):661-7. PubMed ID: 21412164
    [Abstract] [Full Text] [Related]

  • 20. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.
    Desrosiers L, Fadare O, Xiao ZF, Dresser K, Wang SA.
    Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.